Pulse Biosciences (PLSE) Non Operating Income (2020 - 2025)

Pulse Biosciences' Non Operating Income history runs 6 years deep, the most recent figure standing at $1.0 million for Q3 2025.

• On a quarterly basis, Non Operating Income rose 2.67% year-over-year to $1.0 million in Q3 2025; TTM through Sep 2025 was $4.2 million, a 76.34% increase from a year earlier, with the FY2024 full-year figure at $2.7 million, up 95.89% from the prior year.
• Non Operating Income retreated to $1.0 million in Q3 2025 per PLSE's latest filing, from $1.1 million in the prior quarter.
• Across five years, Non Operating Income topped out at $1.2 million in Q1 2025 and bottomed at -$517000.0 in Q2 2021.
• The 5-year median for Non Operating Income is $330000.0 (2023), against an average of $349500.0.
• Across the five-year window, Non Operating Income slumped 7433.33% in 2022 and surged 5000.0% in 2023, its largest moves.
• Year by year, Non Operating Income stood at -$6000.0 in 2021, then slumped by 7433.33% to -$452000.0 in 2022, then surged by 232.74% to $600000.0 in 2023, then surged by 44.67% to $868000.0 in 2024, then gained by 15.32% to $1.0 million in 2025.
• Per Business Quant, the three latest PLSE Non Operating Income figures stand at $1.0 million (Q3 2025), $1.1 million (Q2 2025), and $1.2 million (Q1 2025).